| NPC, n = 198 (%) | Non-NPC, n = 285 (%) | p value | |
---|---|---|---|---|
Primary analysis | Â | Â | Â | |
Occurrence of TLN | 11 (5.6) | 1 (0.4) |  | < 0.01# |
 | Adjusted HR (95% CI) | p value |
---|---|---|
Multi-variable analysis | Â | Â |
Cancer type (NPC vs. non-NPC) | 13.35 (1.37, 130.61) | 0.03†|
Age | 1.04 (0.98, 1.11) | 0.16 |
T3/T4 stage | 3.27 (0.80, 13.27) | 0.10 |
Radiation doses | 1.00 (1.00, 1.00) | 0.01 |
Proton-beam therapy | 1.67 (0.40, 6.94) | 0.48 |
Re-irradiation | 0.87 (0.04, 19.60) | 0.93 |
Time to radiation therapy | 1.00 (0.95, 1.05) | 0.96 |